What is the GENB stock price prediction for next 2 weeks?

According to our price prediction algorithm,Generate Biomedicines, Inc. (GENB) price will be around $14.89 in the next 2 weeks. This means it will increase by 3.612386917188587 from the last closing price. This prediction may vary from other time period filters for GENB stock.

What can be the highest Possible price of GENB stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, GENB can achieve the highest price of $15.81 which is 10.0274931310159 higher than last closing price. This prediction may vary from other time period filters for GENB stock.

What can be the lowest Possible price of GENB stock in next 2 weeks?

As per the forecast and algorithmic analysis, GENB stock price can be as low as $14.00 which is -2.5903002076865964 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for GENB stock.

Will GENB stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that GENB stock will gain3.612386917188587 in the next 2 weeks. This prediction may vary from other time period filters for GENB stock.

What is GENB stock last closing price?

Last closing price of GENB stock was $14.37.

What is GENB stock price prediction?

GENB stock price prediction means predicting the future closing prices of GENB stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of GENB stock in a certain time period.

How we predict GENB stock future prices?

If you are searching for GENB stock forecast, analysis or price prediction, then you might be wondering what Generate Biomedicines, Inc. (GENB) will do in the future. Our GENB price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This GENB price prediction will likely answer most of your questions.

How frequent we update GENB stock predictions?

We are updating the forecasts for the GENB stock on daily basis.

Is using ML forecasting for GENB stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for GENB stock same for all the time periods?

No, the prediction for GENB stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Generate Biomedicines, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$14.3715.24%Since 2 Weeks

Predicted Price$14.893.61%For 2 Weeks

Upper Predicted Price$15.8110.03%For 2 Weeks

Lower Predicted Price$14.00-2.59%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of GENB will rise by +3.61% over the next 2 Weeks and hit $14.89 by Monday, May 25, 2026. In that time frame, GENB's share price is expected to range between $14.00 and $15.81.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 25, 2026	14.00	14.89	15.81
May 22, 2026	13.42	14.39	15.28
May 21, 2026	13.94	14.81	15.71
May 20, 2026	14.03	14.94	15.91
May 19, 2026	14.03	14.89	15.78
May 18, 2026	13.59	14.58	15.55
May 15, 2026	13.19	14.08	15.00
May 14, 2026	13.54	14.50	15.35
May 13, 2026	13.82	14.63	15.53
May 12, 2026	13.63	14.58	15.48

GENB shares rose +5.60% in Tuesday, May 12, 2026's trading session, rising from a previous close of $14.37 to move at $15.18. The stock demonstrated notable intraday movement (see GENB's key stats for a full breakdown), fluctuating between $14.42 and $15.63, a +8.39% trading range. While recent weeks have seen some volatility, GENB has managed to secure a +21.89% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 358.82K shares changing hands, 67.25K more than the previous session. This amounted to $5.45M in total market activity.

Will GENB Continue Its Upward Trend?

According to analyst ratings and projections for GENB, Generate Biomedicines, Inc. shares are anticipated to increase by +4.02%, potentially reaching $15.81 per share by May 25, 2026. Short-term technical indicators currently suggest a neutral sentiment for GENB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the GENB stock forecast, now is a good time to buy GENB stock because its current trading price is +1.92% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on GENB covering social and institutional perspectives.

GENB Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into GENB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 60.21% to 66.24%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 54.86%, suggests a neutral medium-term outlook. Insights into GENB's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Generate Biomedicines Short-Term Forecasts

GENB Forecast For Next 5 Days

Our algorithm anticipates Generate Biomedicines (GENB) stock could hit $13.13 by May 19, 2026. This represents a -13.48% fall from today's price, following a - change over the past five days.

GENB Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Generate Biomedicines, Inc. (GENB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $13.23, which would mean a -12.82% decrease from the current price of $15.18. Projections for this period range from a high of $15.64 to a low of $11.56.

GENB Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Generate Biomedicines's price over the next three months point to a rise. GENB stock is expected to peak at $41.30 on Jul 22, 2026 after potentially dipping to $29.48 on Jul 13, 2026. On average, GENB is likely to trade around $34.42 in the coming 90 days.

Generate Biomedicines Stock Forecast 2025

Based on our predictive models, Generate Biomedicines (GENB) is expected to trade between $29.48 and $41.30 throughout 2026. This would result in an average price of $34.52, potentially offering investors a +127.48% return from current levels.

Generate Biomedicines, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Generate Biomedicines, Inc. (GENB) is positioned to show a strong performance in May 2026. The price is predicted to move between $30.73 and $41.12, settling at an average of $35.89. This could translate to a +136.51% gain.

June 2026

Based on current market signals, Generate Biomedicines, Inc. is projected to trend june 2026. We forecast a trading range from $29.74 to $35.75, with a likely average price of $33.34. Investors could expect a potential return of +119.70%.

July 2026

Our predictive algorithms indicate Generate Biomedicines, Inc. stock may see a shift in July 2026. The expected range spans $29.48–$41.30, with an average target of $34.81. This represents a positive outlook and a possible gain of +129.39%.

August 2026

Analyzing established trends, Generate Biomedicines, Inc. looks set to move in August 2026. Projections place the stock between $30.61 and $36.06, averaging around $33.68. This suggests a +121.94% gain from current levels.

September 2026

Market indicators suggest Generate Biomedicines, Inc. could experience notable changes during September 2026. Prices could fluctuate within $31.49 to $36.11, with a midpoint forecast of $33.55. The stock might deliver a +121.09% gain.

October 2026

Forecasting for October 2026, models estimate that Generate Biomedicines, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $31.56 and $39.80, averaging $35.16. This signals a positive trajectory with potential returns around +131.70%.

November 2026

According to our latest forecast models, Generate Biomedicines, Inc. (GENB) is positioned to show a strong performance in November 2026. The price is predicted to move between $32.10 and $37.61, settling at an average of $34.72. This could translate to a +128.80% gain.

December 2026

Based on current market signals, Generate Biomedicines, Inc. is projected to trend december 2026. We forecast a trading range from $30.11 to $40.72, with a likely average price of $35.39. Investors could expect a potential return of +133.21%.

January 2027

Our predictive algorithms indicate Generate Biomedicines, Inc. stock may see a shift in January 2027. The expected range spans $31.27–$36.68, with an average target of $34.33. This represents a positive outlook and a possible gain of +126.23%.

February 2027

Analyzing established trends, Generate Biomedicines, Inc. looks set to move in February 2027. Projections place the stock between $31.35 and $37.67, averaging around $35.27. This suggests a +132.42% gain from current levels.

March 2027

Market indicators suggest Generate Biomedicines, Inc. could experience notable changes during March 2027. Prices could fluctuate within $29.31 to $38.44, with a midpoint forecast of $34.32. The stock might deliver a +126.16% gain.

April 2027

Forecasting for April 2027, models estimate that Generate Biomedicines, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $27.95 and $35.69, averaging $32.33. This signals a positive trajectory with potential returns around +113.05%.

May 2027

According to our latest forecast models, Generate Biomedicines, Inc. (GENB) is positioned to show a strong performance in May 2027. The price is predicted to move between $31.73 and $36.25, settling at an average of $34.15. This could translate to a +125.04% gain.

GENB's history of dividends and stock splits also plays a role in long-term investor confidence.